海利生物 (603718)

Shanghai Hile Bio-Technology Co., Ltd.

ASH

Tags

SSE 580 IndexAgriculture 50 IndexAgriculture, Forestry, Animal Husbandry, and FisheryAnimal HealthPharmaceutical ManufacturingGene ConceptBiological VaccinesMargin Trading and Securities LendingRestructuring StocksHigh Goodwill

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 65566.22
  • Circulating A-Shares(W): 64897.97
  • Earnings Per Share(RMB): 0.0310
  • Net Assets Per Share(RMB): 2.3395
  • Operating Revenue(W RMB): 14974.20
  • Total Profit(W RMB): 4393.56
  • **Net Profit Attributable to Parent(W RMB) **: 2032.97
  • Net Profit Growth Rate(%): 0.77
  • Weighted Return on Equity(%): 1.2900
  • Operating Cash Flow Per Share(RMB): 0.0560
  • Undistributed Profit Per Share(RMB): 0.7990
  • Capital Reserve Per Share(RMB): 0.4238

2. Main Business

The main business covers:

  • Research, development, and production of in vitro diagnostic reagents for human use
  • Research, development, production, and sales of animal biological products
  • Research, development, production, and sales of oral tissue repair and regeneration materials

3. Company Basic Information

  • Company Name: Shanghai Hile Bio-Technology Co., Ltd.
  • Listing Date: 2015-05-15
  • Industry: Pharmaceutical Manufacturing
  • Address: Room 805, No. 138 Huaihai Middle Road, Huangpu District, Shanghai
  • Website: https://www.hile-bio.com/
  • Company Profile: The company was established through the overall change of Hile Co., Ltd. into a joint stock company. This change used July 31, 2011, as the audit base date, converting the audited net assets of Hile Co., Ltd., confirmed by ShineWing audit report, amounting to RMB 344,999,616.31, into 210,000,000 shares, with the remaining RMB 134,999,616.31 recorded as capital reserve. On December 30, 2011, the company obtained the Business License of Enterprise Legal Person (Registration No.: 310226000000028) from the Shanghai Administration for Market Regulation.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Shanghai Haoyuan Venture Capital Development Co., Ltd. General Legal Person 22619.79 34.85
2 Cathay CES Livestock Breeding Traded Open-End Index Securities Investment Fund Fund 1022.79 1.58

5. Concept Sectors

  • Biological Vaccine
  • Gene Concept
  • Margin Trading & Securities Lending
  • Restructuring Stocks
  • High Goodwill
  • Agriculture 50
  • SSE 580

Remarks

  • Data update date: 2025-11-02
  • Data source: Public Market Information